Is there a better drug than tamoxifen?

Is there a better drug than tamoxifen?

Dec. 11, 2002 (San Antonio, Texas) — Results of a long-term study show the relatively new drug Arimidex appears to work better than the standard medicine tamoxifen in fighting early breast cancer in postmenopausal women.

Can I skip tamoxifen?

SAN FRANCISCO—Breast cancer patients who skip 30% of their tamoxifen doses increase their risk of death from breast cancer by 16%, Scottish researchers reported at the first annual ASCO Breast Cancer Symposium (abstract 130).

Which is safer letrozole or tamoxifen?

In a nutshell. This study compared the safety of two hormonal medications used to treat breast cancer, tamoxifen (Nolvadex) and letrozole (Femara). This study found that tamoxifen was associated with an increased risk of blood clots, while letrozole was associated with an increased risk of angina and heart attacks.

Can tamoxifen damage the liver?

Introduction. Tamoxifen is a nonsteroidal antiestrogen that is widely used in the treatment and prevention of breast cancer. Long term tamoxifen therapy has been associated with development of fatty liver, steatohepatitis, cirrhosis, and rare instances of clinically apparent acute liver injury.

Is there an alternative to tamoxifen?

Raloxifene, trade name Evista, is an estrogen-blocking drug that can serve as an alternative to Tamoxifen. It belongs to a class of estrogen inhibitors called selective estrogen response modulators.

What is tamoxifen used to treat?

Tamoxifen is a drug that is often prescribed for patients who have been diagnosed with estrogen receptor positive (ER+) breast cancers for the purpose of blocking estrogen from binding to the hormone receptor sites with the assumption that it will prevent future estrogen-fueled breast cancers.

Can I Use Nutrition instead of tamoxifen to prevent recurrence?

This means we do not know whether any particular diet or nutritional plan is as effective as tamoxifen for preventing recurrence. If you decide to try nutrition instead of tamoxifen, you are choosing an approach that is not conclusively proven to reduce risk of recurrence in the same way that tamoxifen can reduce risk.

Is tamoxifen a carcinogen?

In 1996, a division of the World Health Organization, the International Agency for Research on Cancer, declared that tamoxifen is a Group I carcinogen, meaning that it can cause cancer.